中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

不同剂量米非司酮治疗子宫肌瘤效果比较

王淑娟,沙利

(陕西省延安市延川县人民医院妇产科,陕西 延安,717200)

浏览次数:108次 下载次数:393次

摘要:

目的 探讨不同剂量米非司酮治疗子宫肌瘤的疗效。方法 选择我院收治的子宫肌瘤患者80例作为研究对象,将患者随机为两组。对照组40例患者采用高剂量米非司酮(25 mg/d)治疗,而观察组40例患者采用低剂量米非司酮(10 mg/d)治疗,比较两组患者临床效果。结果 治疗3个月后,两组患者的子宫肌瘤体积、子宫体积均缩小(P<0.05),但组间差异不显著(P>0.05);两组血清生殖激素水平均降低,且观察组低于对照组(P<0.05);观察组总有效率高于对照组(P<0.05);不良反应总发生率低于对照组(P<0.05)。结论 口服低剂量米非司酮治疗子宫肌瘤疗效满意且安全性高。

关键词:不同剂量;米非司酮;子宫肌瘤

中图分类号:R737.33 文献标志码:A文章编号:2096-1413(2017)21-0038-02

    Effect comparison of different doses of mifepristone in the treatment of uterine fibroids
    WANG Shu-juan, SHA Li
    (Department of Obstetrics and Gynecology, People``s Hospital of Yanchuan County, Yan``an 717200, China)

    ABSTRACT: Objective To investigate the curative effect of different doses of mifepristone in the treatment of uterine fibroids. Methods Eighty cases of patients with uterine fibroids admitted in our hospital were selected as the research objects, all the patients were andomly divided into control group and observation group. Forty patients in the control group accepted high dose mifepristone (25 mg/d) treatment, and 40 patients in the observation group received low dose mifepristone (10 mg/d) treatment. The clinical effects of the two groups were compared. Results After 3 months of treatment, the uterine fibroids volume, uterine volume of the two groups significantly reduced (P<0.05), but the difference between the two groups were not significant (P>0.05); the levels of serum reproductive hormone decreased in both groups, and the observation group was lower than that of the control group (P<0.05); the total effective rate of the observation group was higher than that of the control group (P<0.05); the total incidence of adverse reactions was lower than that of the control group (P<0.05). Conclusion Oral low dose mifepristone applied in the treatment of uterine fibroids can achieve satisfactory efficacy, which has high safety.

    KEYWORDS: different doses; mifepristone; uterine fibroids

    参考文献:
    [1] 冯赛男.子宫肌瘤采用不同剂量米非司酮治疗的临床效果报道[J].大家健康(下旬版),2015,31(3):408-409.
    [2] 贾卫静,江金.米非司酮独用及与宫瘤消胶囊合用治疗子宫肌瘤的效果评价[J].中国生化药物杂志,2014,21(4):111-112,115.
    [3] 卢少燕.子宫肌瘤采用不同剂量米非司酮治疗的临床价值探析[J].现代养生,2015,31(1):261.
    [4] 杨柳,何顺之,黄晓燕,等.米非司酮对减少子宫肌瘤术后再复发的探讨[J].重庆医学,2014,43(17):2209-2211.
    [5] 金秧秧.不同剂量米非司酮治疗子宫肌瘤90例临床疗效分析[J].海峡药学,2015,28(4):172-173.
    [6] 许轶曼.不同剂量米非司酮治疗子宫肌腺症98例临床分析[J].中国伤残医学,2015,23(7):106-107.
    [7] 魏思慧.不同剂量米非司酮治疗子宫肌瘤的效果观察[J].河南医学研究,2015,6(3):118-119.
    [8] 朱婷,张天铭.不同剂量米非司酮治疗子宫肌瘤的临床效果比较[J].中国当代医药,2014,21(28):61-63.
    [9] 黄建芬,林邯枫,林姬.不同剂量米非司酮治疗子宫肌瘤效果比较[J].北方药学,2016,13(29):34-36.
    [10] 何艳.不同剂量米非司酮治疗子宫肌瘤的对比分析[J].基层医学论坛,2013,15(10):1290-1291.

上一篇葛根素联合他汀类药物治疗早期2型糖尿病肾病的效果观察

下一篇县级医院鲍曼不动杆菌感染的特点及耐药分析